That's important, because the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective. To put it simply, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff brown stock picks 2021). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. This was a development nearly no one saw. But it's going to have profound implications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of financial investment opportunities in this space, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (biotech stocks). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it pulled back possibly substantially prior to going greater - genetic sequencer stock jeff brown. I've been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mostly informing readers. But that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old institution. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. exponential tech investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous great personal companies on the brink of striking the general public markets And I've been dealing with a brand-new way for you to invest even before these companies go public.
This chance has been building over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the details. Go right here to reserve your spot for totally free.
Emma Walsh here, managing editor of the Diary. Routine Journal readers know that tech isn't our usual beat (tech predictions). And when it comes to tech investing, we leave it to the experts. Luckily, we have a number of such professionals in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we understand (tech stocks). In truth, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential development and creating amazing opportunities for investors. I desire to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. diplomatic relations. But regardless of what numerous readers may think, this is a pattern that's simply starting. Although the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (longtime readers). Losing two months of production and sales truly impacts the number of 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million units is amazing. More significantly, the delays brought on by the pandemic created a heap of suppressed demand. And that demand is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G devices will be delivered in 2021 - exponential growth. Which's not my only 5G prediction When I've discussed 5G in the past, I've explained its 3 different stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Phase 3, 5G services start to be provided (jeff brown 2021 predictions). That's when we begin to see applications running on 5G networks. Consider things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage 3 by this summertime. This starts something of a virtuous cycle: Many individuals do not truly appreciate the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of amazing applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment opportunities moving forward will be huge. Stepping far from 5G, the next important technology I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar idea however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well understood. And during that time, there were really just three business operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This whole market is successfully a greenfield opportunity.
There's room for numerous business to exist in this area. last week. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary due to the fact that the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has actually been an experimental procedure. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced utilizing this innovation. This was among those advancements that practically no one discovered. However it's going to have profound ramifications for treating disease. And, obviously, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back perhaps substantially before going greater. I've been covering bitcoin for a long time now. One of the very first research study reports I ever released was on bitcoin - brownstone research. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. biotech stock. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date as of February 2021, but we could not individually verify this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent perspective on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares much of his finest choices in the Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he effectively predicted a few of the most significant economic events of the past twenty years. Although he does not appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it best each time, however Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his capability. The Future Report is published by Brownstone Research, a prominent monetary research publisher. Brownstone Research study provides several research services with a variety of specializations - genetic sequencer stock jeff brown.
The business is also associated with Bonner & Partners, another well-respected research study publisher - jeff brown prediction for 2021. On its site, Brownstone states its mission is to provide retail financiers with professional-grade research study: "For too long, the finest financial investment research has actually not been offered to private investors. It has actually been normally scheduled for financial investment banks, hedge funds, private equity, and high-net-worth clients. second wave. The mission of Brownstone Research is to make that type of proprietary research study available to any financiers wanting to get an edge in the markets. The goal is simple to provide special and rewarding financial investment research discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise functions as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you know even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. future report. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In fact, Brown thinks S.A.V. genetic sequencing companies jeff brown. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge technologies: artificial intelligence and electrical automobiles. Musk hopes the combination will assist him develop the very first fully-autonomous, self-driving cars ever. It's nothing brief of the automotive market's Holy Grail. As you know, electrical lorries and self-driving cars and truck stocks have been substantial this year, but the Wall Street machine has actually approved hype without much tangible outcome. Despite an extreme increase in competition over the previous couple of years, Brown still thinks Musk has the best chance of putting all of it together.
tech could be the magic string that connects everything together. S.A.V. represents Shared Autonomous Car, and it might be the future of transportation. Basically, this innovation would allow you to lease your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You just get out of the automobile and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the profits. It sounds insane, however it might be closed than you think.